ADi (ADiTx Therapeutics)

N/A

Report date: 2025/01/26 19:02:35
NME

Base Information

Drug NameADi (ADiTx Therapeutics)
Drug Alias NameApoptotic DNA ImmunotherapyADi (ADiTx Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionImmunosuppressantsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLoma Linda University
China Registration ClassN/A

Develop Information

Active CompaniesAditxt Inc
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A